HUMANWELL HEALTHCARE (GROUP) CO.,LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 21.37 CNY | +2.99% |
|
+8.98% | -14.04% |
| Mar. 29 | Humanwell Healthcare's Profit Drops, Operating Income Climbs in 2023 | MT |
| Mar. 28 | Humanwell Healthcare Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 18,289 | 51,818 | 36,247 | 38,443 | 39,995 | 34,381 | - | - |
| Enterprise Value (EV) 1 | 26,813 | 51,818 | 36,247 | 38,443 | 39,995 | 34,381 | 34,381 | 34,381 |
| P/E ratio | 23.3 x | 40.8 x | 26.2 x | 15.5 x | 19 x | 13.7 x | 11.8 x | 10.6 x |
| Yield | 0.37% | 0.3% | 0.67% | 0.67% | 1.85% | 1.84% | 2.17% | 2.48% |
| Capitalization / Revenue | 0.84 x | 2.54 x | 1.77 x | 1.72 x | 1.63 x | 1.29 x | 1.19 x | 1.1 x |
| EV / Revenue | 0.84 x | 2.54 x | 1.77 x | 1.72 x | 1.63 x | 1.29 x | 1.19 x | 1.1 x |
| EV / EBITDA | 7.48 x | 18.2 x | - | 9.04 x | 9.41 x | 6.82 x | 6.74 x | 5.35 x |
| EV / FCF | - | - | 90,196,276 x | - | - | - | - | - |
| FCF Yield | - | - | 0% | - | - | - | - | - |
| Price to Book | - | 4.86 x | 2.8 x | 2.59 x | 2.38 x | 1.84 x | 1.64 x | 1.53 x |
| Nbr of stocks (in thousands) | 1,353,704 | 1,529,449 | 1,609,533 | 1,609,177 | 1,608,822 | 1,608,822 | - | - |
| Reference price 2 | 13.51 | 33.88 | 22.52 | 23.89 | 24.86 | 21.37 | 21.37 | 21.37 |
| Announcement Date | 4/30/20 | 4/27/21 | 4/27/22 | 3/23/23 | 3/28/24 | - | - | - |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 21,807 | 20,369 | 20,441 | 22,338 | 24,525 | 26,627 | 28,866 | 31,118 |
| EBITDA 1 | 2,444 | 2,847 | - | 4,254 | 4,249 | 5,040 | 5,100 | 6,426 |
| EBIT 1 | 1,840 | 2,174 | 2,272 | 3,516 | 3,447 | 3,987 | 4,420 | 5,259 |
| Operating Margin | 8.44% | 10.67% | 11.12% | 15.74% | 14.06% | 14.97% | 15.31% | 16.9% |
| Earnings before Tax (EBT) 1 | 1,779 | 2,111 | 2,199 | 3,426 | 3,384 | 3,915 | 4,384 | 5,187 |
| Net income 1 | - | 1,149 | 1,390 | 2,484 | 2,134 | 2,541 | 2,958 | 3,280 |
| Net margin | - | 5.64% | 6.8% | 11.12% | 8.7% | 9.54% | 10.25% | 10.54% |
| EPS 2 | 0.5800 | 0.8300 | 0.8600 | 1.540 | 1.310 | 1.560 | 1.810 | 2.010 |
| Free Cash Flow | - | - | 401.9 | - | - | - | - | - |
| FCF margin | - | - | 1.97% | - | - | - | - | - |
| FCF Conversion (EBITDA) | - | - | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | 28.92% | - | - | - | - | - |
| Dividend per Share 2 | 0.0500 | 0.1000 | 0.1500 | 0.1600 | 0.4600 | 0.3930 | 0.4630 | 0.5290 |
| Announcement Date | 4/30/20 | 4/27/21 | 4/27/22 | 3/23/23 | 3/28/24 | - | - | - |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | - | 5,729 | 6,413 | 6,724 | 6,650 | 6,187 | 6,926 | 7,262 |
| EBITDA | - | - | - | - | - | - | - | - |
| EBIT | - | - | - | - | - | - | - | - |
| Operating Margin | - | - | - | - | - | - | - | - |
| Earnings before Tax (EBT) | - | - | - | - | - | - | - | - |
| Net income | 658.5 | - | - | - | - | - | - | - |
| Net margin | - | - | - | - | - | - | - | - |
| EPS | 0.4000 | 0.2800 | 0.2200 | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - | - | - |
| Announcement Date | 8/24/23 | 10/26/23 | 3/28/24 | - | - | - | - | - |
1CNY in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt | 8,524 | - | - | - | - | - | - | - |
| Net Cash position | - | - | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | 3.488 x | - | - | - | - | - | - | - |
| Free Cash Flow | - | - | 402 | - | - | - | - | - |
| ROE (net income / shareholders' equity) | 8.43% | 11.3% | 11.3% | 17.6% | 13.3% | 12.8% | 13.3% | 13.8% |
| ROA (Net income/ Total Assets) | - | 3.45% | 4.03% | 6.96% | - | 5.95% | 6.45% | 6.4% |
| Assets 1 | - | 33,319 | 34,501 | 35,717 | - | 42,702 | 45,862 | 51,249 |
| Book Value Per Share 2 | - | 6.970 | 8.050 | 9.210 | 10.40 | 11.60 | 13.00 | 14.00 |
| Cash Flow per Share 2 | 1.510 | 1.290 | 1.240 | 1.500 | 1.210 | 2.010 | 1.850 | 2.380 |
| Capex 1 | 84.9 | 735 | 1,617 | 3,016 | 1,913 | 1,700 | 850 | 1,700 |
| Capex / Sales | 0.39% | 3.61% | 7.91% | 13.5% | 7.8% | 6.38% | 2.94% | 5.46% |
| Announcement Date | 4/30/20 | 4/27/21 | 4/27/22 | 3/23/23 | 3/28/24 | - | - | - |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
21.37
Average target price
-
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -14.04% | 4.74B | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
- Stock Market
- Equities
- 600079 Stock
- Financials Humanwell Healthcare (Group) Co.,Ltd.
